Wizard game teaches transplant kids about potions (meds)
NCT ID NCT07609303
First seen Jun 24, 2026 · Last updated Aug 19, 2026 · Updated 5 times
Summary
This study tests a tablet game called Mystic Wizard, designed to help children aged 7-14 who have received a solid organ transplant learn about their daily medications. In the game, players act as a young wizard who must give 'potions' to keep a magical flame (representing their transplanted organ) strong. After playing, 15 participants will share their thoughts in interviews and fill out questionnaires to see if the game is easy to use and engaging. The goal is to find out if this kind of game could be a helpful tool for transplant education.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mystic Wizard tablet game
- What this could lead to
- If successful, this game could become a fun, engaging way to teach young transplant patients about their medications and care.
- What could go wrong
- This is a very small, early study with only 15 participants. It only measures opinions and usability, not health outcomes, so the game may not actually improve medication adherence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
7 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Between age 7-17 * History of solid organ transplantation * Current admission in inpatient unit * Able to understand and interact with a tablet-based game in English Exclusion Criteria: * Legal guardian not present to obtain consent * Child with a significant neurological condition, or major developmental disability * Child with active infection of the face or hand * History of severe motion sickness * Severe visual or motor impairment limiting gameplay participation * Acute medical instability * Major surgery within the last 48 hours * Inability to understand English
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Solid organ transplant are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Video game therapy gets bedridden patients back on their feet
- Could a cancer drug stop a deadly complication in transplant patients?
- Small study checks COVID-19 vaccine power in young cancer patients
- Supercharged immune cells take on post-transplant viruses
- Could a double-dose flu vaccine protect vulnerable transplant patients better?
- New hope for HIV patients with organ transplants: simpler drug combo under study